Huifeng Bio-Pharmaceutical Technology has signed an agreement under which it will gain operational control of Xi'an Qinba Xintong Medical Ltd, a medical device company. In exchange for providing management services, Huifeng will receive 70% of Qinba’s profits. Huifeng, which produces plant extracts and pharmaceutical raw materials, intends to turn itself into a vertically integrated producer of finished pharmaceuticals. Huifeng is interested in Qinba because of its relationships with potential clients. More details...

Stock Symbol: (OTCBB: HFGB)